Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Depreciation & Amortization (CF) (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Depreciation & Amortization (CF) readings, the most recent being $2.8 million for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 25.53% to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.6 million, a 26.18% increase, with the full-year FY2025 number at $10.6 million, up 26.18% from a year prior.
  • Depreciation & Amortization (CF) hit $2.8 million in Q4 2025 for Treace Medical Concepts, up from $2.8 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.8 million in Q4 2025 to a low of $100000.0 in Q2 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $1.3 million (2023), compared with a mean of $1.4 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): crashed 75.0% in 2021 and later soared 300.0% in 2022.
  • Treace Medical Concepts' Depreciation & Amortization (CF) stood at $285000.0 in 2021, then skyrocketed by 221.75% to $917000.0 in 2022, then skyrocketed by 92.91% to $1.8 million in 2023, then increased by 26.46% to $2.2 million in 2024, then increased by 25.53% to $2.8 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $2.8 million (Q4 2025), $2.8 million (Q3 2025), and $2.6 million (Q2 2025) per Business Quant data.